Day

February 1, 2021

ZENABIS JOINT VENTURE RECEIVES EU GMP CERTIFICATION

ZENABIS JOINT VENTURE RECEIVES EU GMP CERTIFICATION   Vancouver, British Columbia, February 1, 2021 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company“) announces today that its Maltese joint venture, ZenPharm Limited (“ZenPharm”), has received European Union Good Manufacturing Practices (“EU GMP”) certification issued by the Malta Medicines Authority. EU GMP certification is issued by...
Read More
X